论文信息 - Phase I/II results of a second-generation humanized anti-CD20 antibody, IMMU-106 (hA20), in NHL. - 字舞流文

Phase I/II results of a second-generation humanized anti-CD20 antibody, IMMU-106 (hA20), in NHL.

J. Leonard | B. Coiffier | D. Goldenberg | N. Teoh | W. Wegener | M. Coleman | M. Petillon | A. Bahkti | F. Morshhauser